Quest PharmaTech Announces Results from AGM Canada NewsWire EDMONTON, AB, July 21, 2022 TSX Venture: QPT ...
Quest PharmaTech Provides Corporate Update Canada NewsWire EDMONTON, AB, April 19, 2022 TSX Venture: QPT EDMONTON, AB, April 19, 2022 /CNW/...
OncoQuest Pharmaceuticals Inc. Announces First Patient Enrolled in Each of Two Investigator Initiated Clinical Trials of Oregovomab in...
Quest PharmaTech Announces Results from AGM Canada NewsWire EDMONTON, AB, July 7, 2021 TSX Venture: QPT EDMONTON, AB, July 7, 2021...
Quest PharmaTech announces two presentations by OncoQuest Pharmaceuticals, Inc. at the 2021 Annual Meeting of the American Association of...
Quest Provides Update to Immunotherapy Asset Transfer Between OncoQuest Inc. and OncoQuest Pharmaceuticals Inc. Canada NewsWire EDMONTON, AB...
Quest Announces that OncoQuest Pharmaceuticals Inc. Doses First Patient in Phase 3 Clinical Trial, FLORA-5, of Company's Lead Investigational...
Quest Provides Corporate Update Canada NewsWire EDMONTON, AB, June 4, 2020 TSX Venture: QPT (078590.KOSDAQ) EDMONTON, AB, June 4, 2020 /CNW/...
L'OCRCVM permet la reprise de la négociation - QPT Canada NewsWire VANCOUVER, BC, le 2 juin 2020 VANCOUVER, BC, le 2 juin 2020 /CNW/...
IIROC Trading Resumption - QPT Canada NewsWire VANCOUVER, BC, June 2, 2020 VANCOUVER, BC, June 2, 2020 /CNW/ - Trading resumes in: Company:...
MISE À JOUR - Suspension de la négociation par l'OCRCVM - QPT Canada NewsWire VANCOUVER, le 4 mai 2020 REASON CODE UPDATE...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads